Cost-effectiveness Analysis on Fluoxetine and Paroxetine in the Treatment of Depressive Disorder by Evidence-based Medicine Method / 中国药房
China Pharmacy
;
(12)2005.
Artigo
em Chinês
| WPRIM
| ID: wpr-525652
ABSTRACT
OBJECTIVE:
To evaluate the cost-effectiveness of fluxetine and paroxetine in the treatment of depressive disorders.METHODS:
The clinical data of fluxetine and paroxetine in the treatment of depressive disorders were collected by evidence-based medicine method and which were evaluated by cost-effectiveness analysis in pharmacoeconomics.RESULTS:
The cure rates of fluxetine and paroxetine in the treatment of depressive disorders were36.30%and58.73%,respectively,and the cost-effectiveness ratios of which were14.13and9.73,respectively.The incremental cost-effectiveness ratio of the latter vs.the former was2.60.CONCLUSION:
The cost-effectiveness of paroxetine is superior to fluxetine in the treatment of depressive disorders.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Tipo de estudo:
Avaliação Econômica em Saúde
Idioma:
Chinês
Revista:
China Pharmacy
Ano de publicação:
2005
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS